- Division of Pulmonary and Critical Care Medicine, Beth Israel Medical Center, New York, NY 10003, USA;
ArthurWai Sung,
Email: arthursung@aol.com
Lung cancer management is complex and requires a multi-disciplinary approach to provide comprehensive care. Interventional pulmonology (IP) is an evolving field that utilizes minimally invasive modalities for the initial diagnosis and staging of suspected lung cancers. Endobronchial ultrasound guided sampling of mediastinal lymph nodes for staging and detection of driver mutations is instrumental for prognosis and treatment of early and later stage lung cancers. Advances in navigational bronchoscopy allow for histological sampling of suspicious peripheral lesions with minimal complication rates, as well as assisting with fiducial marker placements for stereotactic radiation therapy. Furthermore, IP can also offer palliation for inoperable cancers and those with late stage diseases. As the trend towards early lung cancer detection with low dose computed tomography is developing, it is paramount for the pulmonary physician with expertise in lung nodule management, minimally invasive sampling and staging to integrate into the paradigm of multi-specialty care.
Citation： RyuPeter Hambrook Tofts, PeterMJ Lee, ArthurWai Sung. Interventional Pulmonology Approaches in the Diagnosis and Treatment of Early Stage Non Small Cell Lung Cancer. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2015, 22(4): 344-354. doi: 10.7507/1007-4848.20150094 Copy
| 1. | Smoking and tobacco use:fast facts.Atlanta:Centers for Disease Control and Prevention.Available online:http://www.cdc.gov/tobacco/data_statistics/fact_sheets/fast_facts. |
| 2. | Jemal A, Siegel R, Xu J, et al.Cancer statistics, 2010.CA Cancer J Clin, 2010, 60:277-300. |
| 3. | Wynder EL, Graham EA.Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma; a study of 684 proved cases.J Am Med Assoc, 1950, 143:329-336. |
| 4. | Schmidt H, Voigt K, Emanuel EJ.The ethics of not hiring smokers.N Engl J Med, 2013, 368:1369-1371. |
| 5. | Silvestri GA, Feller-Kopman D, Chen A, et al.Latest advances in advanced diagnostic and therapeutic pulmonary procedures.Chest, 2012, 142:1636-1644. |
| 6. | Seijo LM, Sterman DH.Interventional pulmonology.N Engl J Med, 2001, 344:740-749. |
| 7. | Levine DJ, Angel LF.Role of the Interventional Pulmonologist.Clin Pulm Med, 2006, 13:128-141. |
| 8. | National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al.Reduced lung-cancer mortality with low-dose computed tomographic screening.N Engl J Med, 2011, 365:395-409. |
| 9. | International Early Lung Cancer Action Program Investigators, Henschke CI, Yankelevitz DF, et al.Survival of patients with stage I lung cancer detected on CT screening.N Engl J Med, 2006, 355:1763-1771. |
| 10. | Rivera MP.Preinvasive lesions of the bronchus.Clin Chest Med, 2011, 32:693-702. |
| 11. | Travis WD, Brambilla E, Noguchi M, et al.International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classifcation of lung adenocarcinoma.J Thorac Oncol, 2011, 6:244-285. |
| 12. | Breuer RH, Pasic A, Smit EF, et al.The natural course of preneoplastic lesions in bronchial epithelium.Clin Cancer Res, 2005, 11:537-543. |
| 13. | Bota S, Auliac JB, Paris C, et al.Follow-up of bronchial precancerous lesions and carcinoma in situ using fuorescence endoscopy.Am J Respir Crit Care Med, 2001, 164:1688-1693. |
| 14. | Kennedy TC, McWilliams A, Edell E, et al.Bronchial intraepithelial neoplasia/early central airways lung cancer:ACCP evidence-based clinical practice guidelines (2nd edition).Chest, 2007, 132:221S-233S. |
| 15. | Ikeda N, Hayashi A, Iwasaki K, et al.Comprehensive diagnostic bronchoscopy of central type early stage lung cancer.Lung Cancer, 2007, 56:295-302. |
| 16. | Principles and Practice of Interventional Pulmonology.Springer, New York, 2013. |
| 17. | Zaric B, Perin B.Use of narrow-band imaging bronchoscopy in detection of lung cancer.Expert Rev Med Devices, 2010, 7:395-406. |
| 18. | Keith RL, Miller YE, Gemmill RM, et al.Angiogenic squamous dysplasia in bronchi of individuals at high risk for lung cancer.Clin Cancer Res, 2000, 6:1616-1625. |
| 19. | Zaric B, Perin B, Becker HD, et al.Combination of narrow band imaging (NBI) and autofuorescence imaging (AFI) videobronchoscopy in endoscopic assessment of lung cancer extension.Med Oncol, 2012, 29:1638-1642. |
| 20. | Vincent BD, Fraig M, Silvestri GA.A pilot study of narrow-band imaging compared to white light bronchoscopy for evaluation of normal airways and premalignant and malignant airways disease.Chest, 2007, 131:1794-1799. |
| 21. | Herth FJ, Eberhardt R, Anantham D, et al.Narrow-band imaging bronchoscopy increases the specifcity of bronchoscopic early lung cancer detection.J Thorac Oncol, 2009, 4:1060-1065. |
| 22. | Zaric B, Becker HD, Perin B, et al.Narrow band imaging videobronchoscopy improves assessment of lung cancer extension and infuences therapeutic strategy.Jpn J Clin Oncol, 2009, 39:657-663. |
| 23. | Detterbeck FC, Lewis SZ, Diekemper R, et al.Executive Summary:Diagnosis and management of lung cancer, 3rd ed:American College of Chest Physicians evidence-based clinical practice guidelines.Chest, 2013, 143:7S-37S. |
| 24. | Schreiber G, McCrory DC.Performance characteristics of different modalities for diagnosis of suspected lung cancer:summary of published evidence.Chest, 2003, 123:115S-128S. |
| 25. | Wang Memoli JS, Nietert PJ, et al.Meta-analysis of guided bronchoscopy for the evaluation of the pulmonary nodule.Chest, 2012, 142:385-393. |
| 26. | Baaklini WA, Reinoso MA, Gorin AB, et al.Diagnostic yield of fberoptic bronchoscopy in evaluating solitary pulmonary nodules.Chest, 2000, 117:1049-1054. |
| 27. | Kurimoto N, Murayama M, Yoshioka S, et al.Assessment of usefulness of endobronchial ultrasonography in determination of depth of tracheobronchial tumor invasion.Chest, 1999, 115:1500-1506. |
| 28. | Baba M, Sekine Y, Suzuki M, et al.Correlation between endobronchial ultrasonography (EBUS) images and histologic findings in normal and tumor-invaded bronchial wall.Lung Cancer, 2002, 35:65-71. |
| 29. | Tanaka F, Muro K, Yamasaki S, et al.Evaluation of tracheo-bronchial wall invasion using transbronchial ultrasonography (TBUS).Eur J Cardiothorac Surg, 2000, 17:570-574. |
| 30. | Gildea TR, Mazzone PJ, Karnak D, et al.Electromagnetic navigation diagnostic bronchoscopy:a prospective study.Am J Respir Crit Care Med, 2006, 174:982-989. |
| 31. | Makris D, Scherpereel A, Leroy S, et al.Electromagnetic navigation diagnostic bronchoscopy for small peripheral lung lesions.Eur Respir J, 2007, 29:1187-1192. |
| 32. | Herth F, Ernst A, Schulz M, et al.Endobronchial ultrasound reliably differentiates between airway infltration and compression by tumor.Chest, 2003, 123:458-462. |
| 33. | Steinfort DP, Khor YH, Manser RL, et al.Radial probe endobronchial ultrasound for the diagnosis of peripheral lung cancer:systematic review and meta-analysis.Eur Respir J, 2011, 37:902-910. |
| 34. | Eberhardt R, Anantham D, Ernst A, et al.Multimodality bronchoscopic diagnosis of peripheral lung lesions:a randomized controlled trial.Am J Respir Crit Care Med, 2007, 176:36-41. |
| 35. | Ernst A, Anantham D.Update on interventional bronchoscopy for the thoracic radiologist.J Thorac Imaging, 2011, 26:263-277. |
| 36. | Eberhardt R, Anantham D, Herth F, et al.Electromagnetic navigation diagnostic bronchoscopy in peripheral lung lesions.Chest, 2007, 131:1800-1805. |
| 37. | Eberhardt R, Anantham D, Ernst A, et al.Multimodality bronchoscopic diagnosis of peripheral lung lesions:a randomized controlled trial.Am J Respir Crit Care Med, 2007, 176:36-41. |
| 38. | Makris D, Scherpereel A, Leroy S, et al.Electromagnetic navigation diagnostic bronchoscopy for small peripheral lung lesions.Eur Respir J, 2007, 29:1187-1192. |
| 39. | Seijo LM, de Torres JP, Lozano MD, et al.Diagnostic yield of electromagnetic navigation bronchoscopy is highly dependent on the presence of a Bronchus sign on CT imaging:results from a prospective study.Chest, 2010, 138:1316-1321. |
| 40. | Lamprecht B, Porsch P, Wegleitner B, et al.Electromagnetic navigation bronchoscopy (ENB):Increasing diagnostic yield.Respir Med, 2012, 106:710-715. |
| 41. | Asano F, Shinagawa N, Ishida T, et al.Virtualbronchoscopic navigation combined with ultrathin bronchoscopy.A randomized clinical trial.Am J Respir Crit Care Med, 2013, 188:327-333. |
| 42. | Eberhardt R, Kahn N, Gompelmann D, et al.LungPointâ€"â€"a new approach to peripheral lesions.J Thorac Oncol, 2010, 5:1559-1563. |
| 43. | Rusch VW, Asamura H, Watanabe H, et al.The IASLC lung cancer staging project:a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classifcation for lung cancer.J Thorac Oncol, 2009, 4:568-577. |
| 44. | De Leyn, Lardinois D, Van Schil PE, et al.ESTS guidelines for preoperative lymph node staging for non-cmall cell lung cancer.Eur J Cardiothoracic Surg, 2007, 32:1-8. |
| 45. | Hwangbo B, Kim SK, Lee HS, et al.Application of endobronchial ultrasound-guided transbronchial needle aspiration following integrated PET/CT in mediastinal staging of potentially operable non-small cell lung cancer.Chest, 2009, 135:1280-1287. |
| 46. | Lee PC, Port JL, Korst RJ, et al.Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer.Ann Thorac Surg, 2007, 84:177-181. |
| 47. | Herth F, Becker HD, Ernst A.Conventional vs endobronchial ultrasound-guided transbronchial needle aspiration:a randomized trial.Chest, 2004, 125:322-325. |
| 48. | Wallace MB, Pascual JM, Raimondo M, et al.Minimally invasive endoscopic staging of suspected lung cancer.JAMA, 2008, 299:54054-540546. |
| 49. | Yasufuku K, Chiyo M, Koh E, et al.Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancer.Lung Cancer, 2005, 50:347-354. |
| 50. | Adams K, Shah PL, Edmonds L, et al.Test performance of endobronchial ultrasound and transbronchial needle aspiration biopsy for mediastinal staging in patients with lung cancer:systematic review and meta-analysis.Thorax, 2009, 64:757-762. |
| 51. | Gu P, Zhao YZ, Jiang LY, et al.Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancer:a systematic review and meta-analysis.Eur J Cancer, 2009, 45:1389-1396. |
| 52. | Varela-Lema L, Fernández-Villar A, Ruano-Ravina A.Effectiveness and safety of endobronchial ultrasound-transbronchial needle aspiration:a systematic review.Eur Respir J, 2009, 33:1156-1164. |
| 53. | Yasufuku K, Pierre A, Darling G, et al.A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer.J Thorac Cardiovasc Surg, 2011, 142:1393-1400.e1. |
| 54. | Vilmann P, Krasnik M, Larsen SS, et al.Transesophageal endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) and endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) biopsy:a combined approach in the evaluation of mediastinal lesions.Endoscopy, 2005, 37:833-839. |
| 55. | Annema JT, van Meerbeeck JP, Rintoul RC, et al.Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer:a randomized trial.JAMA, 2010, 304:2245-52. |
| 56. | Fukuoka M, Wu YL, Thongprasert S, et al.Biomarker analyses and final overall survival results from a phaseâ…¢, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS).J Clin Oncol, 2011, 29:2866-2874. |
| 57. | Kwak EL, Bang YJ, Camidge DR, et al.Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.N Engl J Med, 2010, 363:1693-1703. |
| 58. | Pao W, Miller V, Zakowski M, et al.EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib.Proc Natl Acad Sci U S A, 2004, 101:13306-13311. |
| 59. | McDermott U, Iafrate AJ, Gray NS, et al.Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitors.Cancer Res, 2008, 68:3389-3395. |
| 60. | Kwak EL, Camidge DR, Clark J, et al.Clinical activity observed in a phase I dose escalation trial of an oral c-MET and ALK inhibitor, PF-02341066.J Clin Oncol, 2009, 27:abstr 3509. |
| 61. | Nakajima T, Yasufuku K.How I do itâ€"â€"optimal methodology for multidirectional analysis of endobronchial ultrasound-guided transbronchial needle aspiration samples.J Thorac Oncol, 2011, 6:203-206. |
| 62. | Sakairi Y, Nakajima T, Yasufuku K, et al.EML4-ALK fusion gene assessment using metastatic lymph node samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration.Clin Cancer Res, 2010, 16:4938-4945. |
| 63. | Navani N, Brown JM, Nankivell M, et al.Suitability of endobronchial ultrasound-guided transbronchial needle aspiration specimens for subtyping and genotyping of non-small cell lung cancer:a multicenter study of 774 patients.Am J Respir Crit Care Med, 2012, 185:1316-1322. |
| 64. | Bulman W, Saqi A, Powell CA.Acquisition and processing of endobronchial ultrasound-guided transbronchial needle aspiration specimens in the era of targeted lung cancer chemotherapy.Am J Respir Crit Care Med, 2012, 185:606-611. |
| 65. | Loukeris K, Vazquez MF, Sica G, et al.Cytological cell blocks:Predictors of squamous cell carcinoma and adenocarcinoma subtypes.Diagn Cytopathol 2010.[Epub ahead of print]. |
| 66. | Wallace WA, Rassl DM.Accuracy of cell typing in nonsmall cell lung cancer by EBUS/EUS-FNA cytological samples.Eur Respir J, 2011, 38:911-917. |
| 67. | Micames CG, McCrory DC, Pavey DA, et al.Endoscopic ultrasound-guided fne-needle aspiration for non-small cell lung cancer staging:A systematic review and metaanalysis.Chest, 2007, 131:539-548. |
| 68. | Nasuti JF, Gupta PK, Baloch ZW.Diagnostic value and cost-effectiveness of on-site evaluation of fne-needle aspiration specimens:review of 5, 688 cases.Diagn Cytopathol, 2002, 27:1-4. |
| 69. | Pirker R, Herth FJ, Kerr KM, et al.Consensus for EGFR mutation testing in non-small cell lung cancer:results from a European workshop.J Thorac Oncol, 2010, 5:1706-1713. |
| 70. | Arcila ME, Oxnard GR, Nafa K, et al.Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay.Clin Cancer Res, 2011, 17:1169-1180. |
| 71. | Majem M, Remon J.Tumor heterogeneity:evolution through space and time in EGFR mutant non small cell lung cancer patients.Transl Lung Cancer Res, 2013, 2:226-237. |
| 72. | Sequist LV, Waltman BA, Dias-Santagata D, et al.Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors.Sci Transl Med, 2011, 3:75ra26. |
| 73. | Yano S, Nakataki E, Ohtsuka S, et al.Retreatment of lung adenocarcinoma patients with gefitinib who had experienced favorable results from their initial treatment with this selective epidermal growth factor receptor inhibitor:a report of three cases.Oncol Res, 2005, 15:107-111. |
| 74. | Yoshimoto A, Inuzuka K, Kita T, et al.Remarkable effect of gefitinib retreatment in a patient with nonsmall cell lung cancer who had a complete response to initial gefitinib.Am J Med Sci, 2007, 333:221-225. |
| 75. | Oxnard GR, Arcila ME, Sima CS, et al.Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer:distinct natural history of patients with tumors harboring the T790M mutation.Clin Cancer Res, 2011, 17:1616-1622. |
| 76. | Ohashi K, Sequist LV, Arcila ME, et al.Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1.Proc Natl Acad Sci U S A, 2012, 109:E2127-E2133. |
| 77. | Eberhardt R, Kahn N, Herth FJ.‘Heat and destroy’:bronchoscopic-guided therapy of peripheral lung lesions.Respiration, 2010, 79:265-273. |
| 78. | Anantham D, Feller-Kopman D, Shanmugham LN, et al.Electromagnetic navigation bronchoscopy-guided fducial placement for robotic stereotactic radiosurgery of lung tumors:a feasibility study.Chest, 2007, 132:930-935. |
| 79. | Ginsberg RJ, Rubinstein LV.Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer.Lung Cancer Study Group.Ann Thorac Surg, 1995, 60:615-622;discussion 622-623. |
| 80. | Narsule CK, Ebright MI, Fernando HC.Sublobar versus lobar resection:current status.Cancer J, 2011, 17:23-27. |
| 81. | Timmerman R, McGarry R, Yiannoutsos C, et al.Excessive toxicity when treating central tumors in a phaseâ…¡study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer.J Clin Oncol, 2006, 24:4833-4839. |
| 82. | Timmerman R, Papiez L, McGarry R, et al.Extracranial stereotactic radioablation:results of a phase I study in medically inoperable stage I non-small cell lung cancer.Chest, 2003, 124:1946-1955. |
| 83. | Whyte RI, Crownover R, Murphy MJ, et al.Stereotactic radiosurgery for lung tumors:preliminary report of a phase I trial.Ann Thorac Surg, 2003, 75:1097-1101. |
| 84. | Prasad V, Chan RP, Faughnan ME.Embolotherapy of pulmonary arteriovenous malformations:effcacy of platinum versus stainless steel coils.J Vasc Interv Radiol, 2004, 15:153-160. |
| 85. | Mager JJ, Overtoom TT, Blauw H, et al.Embolotherapy of pulmonary arteriovenous malformations:long-term results in 112 patients.J Vasc Interv Radiol, 2004, 15:451-456. |
| 86. | Schroeder C, Hejal R, Linden PA.Coil spring fducial markers placed safely using navigation bronchoscopy in inoperable patients allows accurate delivery of CyberKnife stereotactic radiosurgery.J Thorac Cardiovasc Surg, 2010, 140:1137-1142. |
| 87. | Harley DP, Krimsky WS, Sarkar S, et al.Fiducial marker placement using endobronchial ultrasound and navigational bronchoscopy for stereotactic radiosurgery:an alternative strategy.Ann Thorac Surg, 2010, 89:368-373;discussion 373-374. |
| 88. | de Aquino Gorayeb MM, Gregório MG, de Oliveira EQ, et al.High-dose-rate brachytherapy in symptom palliation due to malignant endobronchial obstruction:A quantitative assessment.Brachytherapy, 2013, 12:471-478. |
| 89. | Nori D, Allison R, Kaplan B, et al.High dose-rate intraluminal irradiation in bronchogenic carcinoma.Technique and results.Chest, 1993, 104:1006-1011. |
| 90. | Nag S, Cano ER, Demanes DJ, et al.The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for head-and-neck carcinoma.Int J Radiat Oncol Biol Phys, 2001, 50:1190-1198. |
| 91. | Guarnaschelli JN, Jose BO.Palliative high-dose-rate endobronchial brachytherapy for recurrent carcinoma:the University of Louisville experience.J Palliat Med, 2010, 13:981-989. |
| 92. | Ung YC, Yu E, Falkson C, et al.The role of high-dose-rate brachytherapy in the palliation of symptoms in patients with non-small-cell lung cancer:a systematic review.Brachytherapy, 2006, 5:189-202. |
| 93. | Kelly JF, Delclos ME, Morice RC, et al.High-dose-rate endobronchial brachytherapy effectively palliates symptoms due to airway tumors:the 10-year M.D.Anderson cancer center experience.Int J Radiat Oncol Biol Phys, 2000, 48:697-702. |
| 94. | Usuda J, Tsutsui H, Honda H, et al.Photodynamic therapy for lung cancers based on novel photodynamic diagnosis using talaporfin sodium (NPe6) and autofuorescence bronchoscopy.Lung Cancer, 2007, 58:317-23. |
| 95. | Sutedja TG.Photodynamic therapy in advanced tracheobronchial cancers.Diagn Ther Endosc, 1999, 5:245-51. |
| 96. | Owen J, Carroll C, Cooke J, et al.School-linked sexual health services for young people (SSHYP):a survey and systematic review concerning current models, effectiveness, cost-effectiveness and research opportunities.Health Technol Assess, 2010, 14:1-228, iii-iv. |
| 97. | Loewen GM, Pandey R, Bellnier D, et al.Endobronchial photodynamic therapy for lung cancer.Lasers Surg Med, 2006, 38:364-370. |
| 98. | Martin LK, Otterson GA, Bekaii-Saab T.Photodynamic therapy (PDT) may provide effective palliation in the treatment of primary tracheal carcinoma:a small case series.Photomed Laser Surg, 2012, 30:668-671. |
| 99. | Kato H.Our experience with photodynamic diagnosis and photodynamic therapy for lung cancer.J Natl Compr Canc Netw, 2012, 10, Suppl, 2:S3-S8. |
| 100. | Furukawa K, Okunaka T, Yamamoto H, et al.Effectiveness of photodynamic therapy and nd-yag laser treatment for obstructed tracheobronchial malignancies.Diagn Ther Endosc, 1999, 5:161-166. |
| 101. | Usuda J, Kato H, Okunaka T, et al.Photodynamic therapy (PDT) for lung cancers.J Thorac Oncol, 2006, 1:489-493. |
| 102. | Maiwand MO.The role of cryosurgery in palliation of tracheo-bronchial carcinoma.Eur J Cardiothorac Surg, 1999, 15:764-768. |
| 103. | Maiwand MO, Asimakopoulos G.Cryosurgery for lung cancer:clinical results and technical aspects.Technol Cancer Res Treat, 2004, 3:143-150. |
| 104. | Homasson JP, Renault P, Angebault M, et al.Bronchoscopic cryotherapy for airway strictures caused by tumors.Chest, 1986, 90:159-164. |
| 105. | Asimakopoulos G, Beeson J, Evans J, et al.Cryosurgery for malignant endobronchial tumors:analysis of outcome.Chest, 2005, 127:2007-2014. |
| 106. | Lee SH, Choi WJ, Sung SW, et al.Endoscopic cryotherapy of lung and bronchial tumors:a systematic review.Korean J Intern Med, 2011, 26:137-144. |
| 107. | Chin CS, Litle V, Yun J, et al.Airway stents.Ann Thorac Surg, 2008, 85:S792-S796. |
| 108. | Theodore PR.Emergent management of malignancy-related acute airway obstruction.Emerg Med Clin North Am, 2009, 27:231-241. |
| 109. | Wood D.Airway stenting.Chest Surg Clin N Am, 2003, 13:211-229. |
| 110. | Lee P, Kupeli E, Mehta AC.Airway stents.Clin Chest Med, 2010, 31:141-150. |
| 111. | Chhajed PN, Baty F, Pless M, et al.Outcome of treated advanced non-small cell lung cancer with and without central airway obstruction.Chest, 2006, 130:1803-1807. |
| 112. | Razi SS, Lebovics RS, Schwartz G, et al.Timely airway stenting improves survival in patients with malignant central airway obstruction.Ann Thorac Surg, 2010, 90:1088-1093. |
- 1. Smoking and tobacco use:fast facts.Atlanta:Centers for Disease Control and Prevention.Available online:http://www.cdc.gov/tobacco/data_statistics/fact_sheets/fast_facts.
- 2. Jemal A, Siegel R, Xu J, et al.Cancer statistics, 2010.CA Cancer J Clin, 2010, 60:277-300.
- 3. Wynder EL, Graham EA.Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma; a study of 684 proved cases.J Am Med Assoc, 1950, 143:329-336.
- 4. Schmidt H, Voigt K, Emanuel EJ.The ethics of not hiring smokers.N Engl J Med, 2013, 368:1369-1371.
- 5. Silvestri GA, Feller-Kopman D, Chen A, et al.Latest advances in advanced diagnostic and therapeutic pulmonary procedures.Chest, 2012, 142:1636-1644.
- 6. Seijo LM, Sterman DH.Interventional pulmonology.N Engl J Med, 2001, 344:740-749.
- 7. Levine DJ, Angel LF.Role of the Interventional Pulmonologist.Clin Pulm Med, 2006, 13:128-141.
- 8. National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al.Reduced lung-cancer mortality with low-dose computed tomographic screening.N Engl J Med, 2011, 365:395-409.
- 9. International Early Lung Cancer Action Program Investigators, Henschke CI, Yankelevitz DF, et al.Survival of patients with stage I lung cancer detected on CT screening.N Engl J Med, 2006, 355:1763-1771.
- 10. Rivera MP.Preinvasive lesions of the bronchus.Clin Chest Med, 2011, 32:693-702.
- 11. Travis WD, Brambilla E, Noguchi M, et al.International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classifcation of lung adenocarcinoma.J Thorac Oncol, 2011, 6:244-285.
- 12. Breuer RH, Pasic A, Smit EF, et al.The natural course of preneoplastic lesions in bronchial epithelium.Clin Cancer Res, 2005, 11:537-543.
- 13. Bota S, Auliac JB, Paris C, et al.Follow-up of bronchial precancerous lesions and carcinoma in situ using fuorescence endoscopy.Am J Respir Crit Care Med, 2001, 164:1688-1693.
- 14. Kennedy TC, McWilliams A, Edell E, et al.Bronchial intraepithelial neoplasia/early central airways lung cancer:ACCP evidence-based clinical practice guidelines (2nd edition).Chest, 2007, 132:221S-233S.
- 15. Ikeda N, Hayashi A, Iwasaki K, et al.Comprehensive diagnostic bronchoscopy of central type early stage lung cancer.Lung Cancer, 2007, 56:295-302.
- 16. Principles and Practice of Interventional Pulmonology.Springer, New York, 2013.
- 17. Zaric B, Perin B.Use of narrow-band imaging bronchoscopy in detection of lung cancer.Expert Rev Med Devices, 2010, 7:395-406.
- 18. Keith RL, Miller YE, Gemmill RM, et al.Angiogenic squamous dysplasia in bronchi of individuals at high risk for lung cancer.Clin Cancer Res, 2000, 6:1616-1625.
- 19. Zaric B, Perin B, Becker HD, et al.Combination of narrow band imaging (NBI) and autofuorescence imaging (AFI) videobronchoscopy in endoscopic assessment of lung cancer extension.Med Oncol, 2012, 29:1638-1642.
- 20. Vincent BD, Fraig M, Silvestri GA.A pilot study of narrow-band imaging compared to white light bronchoscopy for evaluation of normal airways and premalignant and malignant airways disease.Chest, 2007, 131:1794-1799.
- 21. Herth FJ, Eberhardt R, Anantham D, et al.Narrow-band imaging bronchoscopy increases the specifcity of bronchoscopic early lung cancer detection.J Thorac Oncol, 2009, 4:1060-1065.
- 22. Zaric B, Becker HD, Perin B, et al.Narrow band imaging videobronchoscopy improves assessment of lung cancer extension and infuences therapeutic strategy.Jpn J Clin Oncol, 2009, 39:657-663.
- 23. Detterbeck FC, Lewis SZ, Diekemper R, et al.Executive Summary:Diagnosis and management of lung cancer, 3rd ed:American College of Chest Physicians evidence-based clinical practice guidelines.Chest, 2013, 143:7S-37S.
- 24. Schreiber G, McCrory DC.Performance characteristics of different modalities for diagnosis of suspected lung cancer:summary of published evidence.Chest, 2003, 123:115S-128S.
- 25. Wang Memoli JS, Nietert PJ, et al.Meta-analysis of guided bronchoscopy for the evaluation of the pulmonary nodule.Chest, 2012, 142:385-393.
- 26. Baaklini WA, Reinoso MA, Gorin AB, et al.Diagnostic yield of fberoptic bronchoscopy in evaluating solitary pulmonary nodules.Chest, 2000, 117:1049-1054.
- 27. Kurimoto N, Murayama M, Yoshioka S, et al.Assessment of usefulness of endobronchial ultrasonography in determination of depth of tracheobronchial tumor invasion.Chest, 1999, 115:1500-1506.
- 28. Baba M, Sekine Y, Suzuki M, et al.Correlation between endobronchial ultrasonography (EBUS) images and histologic findings in normal and tumor-invaded bronchial wall.Lung Cancer, 2002, 35:65-71.
- 29. Tanaka F, Muro K, Yamasaki S, et al.Evaluation of tracheo-bronchial wall invasion using transbronchial ultrasonography (TBUS).Eur J Cardiothorac Surg, 2000, 17:570-574.
- 30. Gildea TR, Mazzone PJ, Karnak D, et al.Electromagnetic navigation diagnostic bronchoscopy:a prospective study.Am J Respir Crit Care Med, 2006, 174:982-989.
- 31. Makris D, Scherpereel A, Leroy S, et al.Electromagnetic navigation diagnostic bronchoscopy for small peripheral lung lesions.Eur Respir J, 2007, 29:1187-1192.
- 32. Herth F, Ernst A, Schulz M, et al.Endobronchial ultrasound reliably differentiates between airway infltration and compression by tumor.Chest, 2003, 123:458-462.
- 33. Steinfort DP, Khor YH, Manser RL, et al.Radial probe endobronchial ultrasound for the diagnosis of peripheral lung cancer:systematic review and meta-analysis.Eur Respir J, 2011, 37:902-910.
- 34. Eberhardt R, Anantham D, Ernst A, et al.Multimodality bronchoscopic diagnosis of peripheral lung lesions:a randomized controlled trial.Am J Respir Crit Care Med, 2007, 176:36-41.
- 35. Ernst A, Anantham D.Update on interventional bronchoscopy for the thoracic radiologist.J Thorac Imaging, 2011, 26:263-277.
- 36. Eberhardt R, Anantham D, Herth F, et al.Electromagnetic navigation diagnostic bronchoscopy in peripheral lung lesions.Chest, 2007, 131:1800-1805.
- 37. Eberhardt R, Anantham D, Ernst A, et al.Multimodality bronchoscopic diagnosis of peripheral lung lesions:a randomized controlled trial.Am J Respir Crit Care Med, 2007, 176:36-41.
- 38. Makris D, Scherpereel A, Leroy S, et al.Electromagnetic navigation diagnostic bronchoscopy for small peripheral lung lesions.Eur Respir J, 2007, 29:1187-1192.
- 39. Seijo LM, de Torres JP, Lozano MD, et al.Diagnostic yield of electromagnetic navigation bronchoscopy is highly dependent on the presence of a Bronchus sign on CT imaging:results from a prospective study.Chest, 2010, 138:1316-1321.
- 40. Lamprecht B, Porsch P, Wegleitner B, et al.Electromagnetic navigation bronchoscopy (ENB):Increasing diagnostic yield.Respir Med, 2012, 106:710-715.
- 41. Asano F, Shinagawa N, Ishida T, et al.Virtualbronchoscopic navigation combined with ultrathin bronchoscopy.A randomized clinical trial.Am J Respir Crit Care Med, 2013, 188:327-333.
- 42. Eberhardt R, Kahn N, Gompelmann D, et al.LungPointâ€"â€"a new approach to peripheral lesions.J Thorac Oncol, 2010, 5:1559-1563.
- 43. Rusch VW, Asamura H, Watanabe H, et al.The IASLC lung cancer staging project:a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classifcation for lung cancer.J Thorac Oncol, 2009, 4:568-577.
- 44. De Leyn, Lardinois D, Van Schil PE, et al.ESTS guidelines for preoperative lymph node staging for non-cmall cell lung cancer.Eur J Cardiothoracic Surg, 2007, 32:1-8.
- 45. Hwangbo B, Kim SK, Lee HS, et al.Application of endobronchial ultrasound-guided transbronchial needle aspiration following integrated PET/CT in mediastinal staging of potentially operable non-small cell lung cancer.Chest, 2009, 135:1280-1287.
- 46. Lee PC, Port JL, Korst RJ, et al.Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer.Ann Thorac Surg, 2007, 84:177-181.
- 47. Herth F, Becker HD, Ernst A.Conventional vs endobronchial ultrasound-guided transbronchial needle aspiration:a randomized trial.Chest, 2004, 125:322-325.
- 48. Wallace MB, Pascual JM, Raimondo M, et al.Minimally invasive endoscopic staging of suspected lung cancer.JAMA, 2008, 299:54054-540546.
- 49. Yasufuku K, Chiyo M, Koh E, et al.Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancer.Lung Cancer, 2005, 50:347-354.
- 50. Adams K, Shah PL, Edmonds L, et al.Test performance of endobronchial ultrasound and transbronchial needle aspiration biopsy for mediastinal staging in patients with lung cancer:systematic review and meta-analysis.Thorax, 2009, 64:757-762.
- 51. Gu P, Zhao YZ, Jiang LY, et al.Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancer:a systematic review and meta-analysis.Eur J Cancer, 2009, 45:1389-1396.
- 52. Varela-Lema L, Fernández-Villar A, Ruano-Ravina A.Effectiveness and safety of endobronchial ultrasound-transbronchial needle aspiration:a systematic review.Eur Respir J, 2009, 33:1156-1164.
- 53. Yasufuku K, Pierre A, Darling G, et al.A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer.J Thorac Cardiovasc Surg, 2011, 142:1393-1400.e1.
- 54. Vilmann P, Krasnik M, Larsen SS, et al.Transesophageal endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) and endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) biopsy:a combined approach in the evaluation of mediastinal lesions.Endoscopy, 2005, 37:833-839.
- 55. Annema JT, van Meerbeeck JP, Rintoul RC, et al.Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer:a randomized trial.JAMA, 2010, 304:2245-52.
- 56. Fukuoka M, Wu YL, Thongprasert S, et al.Biomarker analyses and final overall survival results from a phaseâ…¢, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS).J Clin Oncol, 2011, 29:2866-2874.
- 57. Kwak EL, Bang YJ, Camidge DR, et al.Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.N Engl J Med, 2010, 363:1693-1703.
- 58. Pao W, Miller V, Zakowski M, et al.EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib.Proc Natl Acad Sci U S A, 2004, 101:13306-13311.
- 59. McDermott U, Iafrate AJ, Gray NS, et al.Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitors.Cancer Res, 2008, 68:3389-3395.
- 60. Kwak EL, Camidge DR, Clark J, et al.Clinical activity observed in a phase I dose escalation trial of an oral c-MET and ALK inhibitor, PF-02341066.J Clin Oncol, 2009, 27:abstr 3509.
- 61. Nakajima T, Yasufuku K.How I do itâ€"â€"optimal methodology for multidirectional analysis of endobronchial ultrasound-guided transbronchial needle aspiration samples.J Thorac Oncol, 2011, 6:203-206.
- 62. Sakairi Y, Nakajima T, Yasufuku K, et al.EML4-ALK fusion gene assessment using metastatic lymph node samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration.Clin Cancer Res, 2010, 16:4938-4945.
- 63. Navani N, Brown JM, Nankivell M, et al.Suitability of endobronchial ultrasound-guided transbronchial needle aspiration specimens for subtyping and genotyping of non-small cell lung cancer:a multicenter study of 774 patients.Am J Respir Crit Care Med, 2012, 185:1316-1322.
- 64. Bulman W, Saqi A, Powell CA.Acquisition and processing of endobronchial ultrasound-guided transbronchial needle aspiration specimens in the era of targeted lung cancer chemotherapy.Am J Respir Crit Care Med, 2012, 185:606-611.
- 65. Loukeris K, Vazquez MF, Sica G, et al.Cytological cell blocks:Predictors of squamous cell carcinoma and adenocarcinoma subtypes.Diagn Cytopathol 2010.[Epub ahead of print].
- 66. Wallace WA, Rassl DM.Accuracy of cell typing in nonsmall cell lung cancer by EBUS/EUS-FNA cytological samples.Eur Respir J, 2011, 38:911-917.
- 67. Micames CG, McCrory DC, Pavey DA, et al.Endoscopic ultrasound-guided fne-needle aspiration for non-small cell lung cancer staging:A systematic review and metaanalysis.Chest, 2007, 131:539-548.
- 68. Nasuti JF, Gupta PK, Baloch ZW.Diagnostic value and cost-effectiveness of on-site evaluation of fne-needle aspiration specimens:review of 5, 688 cases.Diagn Cytopathol, 2002, 27:1-4.
- 69. Pirker R, Herth FJ, Kerr KM, et al.Consensus for EGFR mutation testing in non-small cell lung cancer:results from a European workshop.J Thorac Oncol, 2010, 5:1706-1713.
- 70. Arcila ME, Oxnard GR, Nafa K, et al.Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay.Clin Cancer Res, 2011, 17:1169-1180.
- 71. Majem M, Remon J.Tumor heterogeneity:evolution through space and time in EGFR mutant non small cell lung cancer patients.Transl Lung Cancer Res, 2013, 2:226-237.
- 72. Sequist LV, Waltman BA, Dias-Santagata D, et al.Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors.Sci Transl Med, 2011, 3:75ra26.
- 73. Yano S, Nakataki E, Ohtsuka S, et al.Retreatment of lung adenocarcinoma patients with gefitinib who had experienced favorable results from their initial treatment with this selective epidermal growth factor receptor inhibitor:a report of three cases.Oncol Res, 2005, 15:107-111.
- 74. Yoshimoto A, Inuzuka K, Kita T, et al.Remarkable effect of gefitinib retreatment in a patient with nonsmall cell lung cancer who had a complete response to initial gefitinib.Am J Med Sci, 2007, 333:221-225.
- 75. Oxnard GR, Arcila ME, Sima CS, et al.Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer:distinct natural history of patients with tumors harboring the T790M mutation.Clin Cancer Res, 2011, 17:1616-1622.
- 76. Ohashi K, Sequist LV, Arcila ME, et al.Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1.Proc Natl Acad Sci U S A, 2012, 109:E2127-E2133.
- 77. Eberhardt R, Kahn N, Herth FJ.‘Heat and destroy’:bronchoscopic-guided therapy of peripheral lung lesions.Respiration, 2010, 79:265-273.
- 78. Anantham D, Feller-Kopman D, Shanmugham LN, et al.Electromagnetic navigation bronchoscopy-guided fducial placement for robotic stereotactic radiosurgery of lung tumors:a feasibility study.Chest, 2007, 132:930-935.
- 79. Ginsberg RJ, Rubinstein LV.Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer.Lung Cancer Study Group.Ann Thorac Surg, 1995, 60:615-622;discussion 622-623.
- 80. Narsule CK, Ebright MI, Fernando HC.Sublobar versus lobar resection:current status.Cancer J, 2011, 17:23-27.
- 81. Timmerman R, McGarry R, Yiannoutsos C, et al.Excessive toxicity when treating central tumors in a phaseâ…¡study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer.J Clin Oncol, 2006, 24:4833-4839.
- 82. Timmerman R, Papiez L, McGarry R, et al.Extracranial stereotactic radioablation:results of a phase I study in medically inoperable stage I non-small cell lung cancer.Chest, 2003, 124:1946-1955.
- 83. Whyte RI, Crownover R, Murphy MJ, et al.Stereotactic radiosurgery for lung tumors:preliminary report of a phase I trial.Ann Thorac Surg, 2003, 75:1097-1101.
- 84. Prasad V, Chan RP, Faughnan ME.Embolotherapy of pulmonary arteriovenous malformations:effcacy of platinum versus stainless steel coils.J Vasc Interv Radiol, 2004, 15:153-160.
- 85. Mager JJ, Overtoom TT, Blauw H, et al.Embolotherapy of pulmonary arteriovenous malformations:long-term results in 112 patients.J Vasc Interv Radiol, 2004, 15:451-456.
- 86. Schroeder C, Hejal R, Linden PA.Coil spring fducial markers placed safely using navigation bronchoscopy in inoperable patients allows accurate delivery of CyberKnife stereotactic radiosurgery.J Thorac Cardiovasc Surg, 2010, 140:1137-1142.
- 87. Harley DP, Krimsky WS, Sarkar S, et al.Fiducial marker placement using endobronchial ultrasound and navigational bronchoscopy for stereotactic radiosurgery:an alternative strategy.Ann Thorac Surg, 2010, 89:368-373;discussion 373-374.
- 88. de Aquino Gorayeb MM, Gregório MG, de Oliveira EQ, et al.High-dose-rate brachytherapy in symptom palliation due to malignant endobronchial obstruction:A quantitative assessment.Brachytherapy, 2013, 12:471-478.
- 89. Nori D, Allison R, Kaplan B, et al.High dose-rate intraluminal irradiation in bronchogenic carcinoma.Technique and results.Chest, 1993, 104:1006-1011.
- 90. Nag S, Cano ER, Demanes DJ, et al.The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for head-and-neck carcinoma.Int J Radiat Oncol Biol Phys, 2001, 50:1190-1198.
- 91. Guarnaschelli JN, Jose BO.Palliative high-dose-rate endobronchial brachytherapy for recurrent carcinoma:the University of Louisville experience.J Palliat Med, 2010, 13:981-989.
- 92. Ung YC, Yu E, Falkson C, et al.The role of high-dose-rate brachytherapy in the palliation of symptoms in patients with non-small-cell lung cancer:a systematic review.Brachytherapy, 2006, 5:189-202.
- 93. Kelly JF, Delclos ME, Morice RC, et al.High-dose-rate endobronchial brachytherapy effectively palliates symptoms due to airway tumors:the 10-year M.D.Anderson cancer center experience.Int J Radiat Oncol Biol Phys, 2000, 48:697-702.
- 94. Usuda J, Tsutsui H, Honda H, et al.Photodynamic therapy for lung cancers based on novel photodynamic diagnosis using talaporfin sodium (NPe6) and autofuorescence bronchoscopy.Lung Cancer, 2007, 58:317-23.
- 95. Sutedja TG.Photodynamic therapy in advanced tracheobronchial cancers.Diagn Ther Endosc, 1999, 5:245-51.
- 96. Owen J, Carroll C, Cooke J, et al.School-linked sexual health services for young people (SSHYP):a survey and systematic review concerning current models, effectiveness, cost-effectiveness and research opportunities.Health Technol Assess, 2010, 14:1-228, iii-iv.
- 97. Loewen GM, Pandey R, Bellnier D, et al.Endobronchial photodynamic therapy for lung cancer.Lasers Surg Med, 2006, 38:364-370.
- 98. Martin LK, Otterson GA, Bekaii-Saab T.Photodynamic therapy (PDT) may provide effective palliation in the treatment of primary tracheal carcinoma:a small case series.Photomed Laser Surg, 2012, 30:668-671.
- 99. Kato H.Our experience with photodynamic diagnosis and photodynamic therapy for lung cancer.J Natl Compr Canc Netw, 2012, 10, Suppl, 2:S3-S8.
- 100. Furukawa K, Okunaka T, Yamamoto H, et al.Effectiveness of photodynamic therapy and nd-yag laser treatment for obstructed tracheobronchial malignancies.Diagn Ther Endosc, 1999, 5:161-166.
- 101. Usuda J, Kato H, Okunaka T, et al.Photodynamic therapy (PDT) for lung cancers.J Thorac Oncol, 2006, 1:489-493.
- 102. Maiwand MO.The role of cryosurgery in palliation of tracheo-bronchial carcinoma.Eur J Cardiothorac Surg, 1999, 15:764-768.
- 103. Maiwand MO, Asimakopoulos G.Cryosurgery for lung cancer:clinical results and technical aspects.Technol Cancer Res Treat, 2004, 3:143-150.
- 104. Homasson JP, Renault P, Angebault M, et al.Bronchoscopic cryotherapy for airway strictures caused by tumors.Chest, 1986, 90:159-164.
- 105. Asimakopoulos G, Beeson J, Evans J, et al.Cryosurgery for malignant endobronchial tumors:analysis of outcome.Chest, 2005, 127:2007-2014.
- 106. Lee SH, Choi WJ, Sung SW, et al.Endoscopic cryotherapy of lung and bronchial tumors:a systematic review.Korean J Intern Med, 2011, 26:137-144.
- 107. Chin CS, Litle V, Yun J, et al.Airway stents.Ann Thorac Surg, 2008, 85:S792-S796.
- 108. Theodore PR.Emergent management of malignancy-related acute airway obstruction.Emerg Med Clin North Am, 2009, 27:231-241.
- 109. Wood D.Airway stenting.Chest Surg Clin N Am, 2003, 13:211-229.
- 110. Lee P, Kupeli E, Mehta AC.Airway stents.Clin Chest Med, 2010, 31:141-150.
- 111. Chhajed PN, Baty F, Pless M, et al.Outcome of treated advanced non-small cell lung cancer with and without central airway obstruction.Chest, 2006, 130:1803-1807.
- 112. Razi SS, Lebovics RS, Schwartz G, et al.Timely airway stenting improves survival in patients with malignant central airway obstruction.Ann Thorac Surg, 2010, 90:1088-1093.